BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24316398)

  • 1. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
    Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome.
    El-Salhy M; Hatlebakk JG; Gilja OH; Hausken T
    Peptides; 2015 May; 67():12-9. PubMed ID: 25765365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine cells in the ileum of patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
    World J Gastroenterol; 2014 Mar; 20(9):2383-91. PubMed ID: 24605036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH
    BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease.
    El-Salhy M; Wendelbo I; Gundersen D
    Mol Med Rep; 2013 Aug; 8(2):451-5. PubMed ID: 23778763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
    El-Salhy M; Wendelbo IH; Gundersen D
    Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome.
    El-Salhy M; Gundersen D; Ostgaard H; Lomholt-Beck B; Hatlebakk JG; Hausken T
    Dig Dis Sci; 2012 Apr; 57(4):873-8. PubMed ID: 22057239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
    El-Salhy M; Hatlebakk JG; Hausken T
    World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stomach antral endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH; Hatlebakk JG; Hausken T
    Int J Mol Med; 2014 Oct; 34(4):967-74. PubMed ID: 25110039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
    El-Salhy M; Mazzawi T; Gundersen D; Hausken T
    Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome.
    Mazzawi T; Hausken T; Gundersen D; El-Salhy M
    Eur J Clin Nutr; 2016 Feb; 70(2):175-81. PubMed ID: 26603880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.
    El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
    Scand J Gastroenterol; 2017 Dec; 52(12):1331-1339. PubMed ID: 28853300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report.
    El-Salhy M; Mazzawi T; Gundersen D; Hatlebakk JG; Hausken T
    BMC Res Notes; 2013 Sep; 6():391. PubMed ID: 24073715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Vaali K; Dizdar V; Hausken T
    Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease.
    Wendelbo I; Mazzawi T; El-Salhy M
    Mol Med Rep; 2014 Jan; 9(1):180-4. PubMed ID: 24213511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS).
    El-Salhy M; Hatlebakk JG; Hausken T
    Neuropeptides; 2020 Feb; 79():101973. PubMed ID: 31727345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH; Gundersen D; Hausken T
    World J Gastrointest Endosc; 2014 May; 6(5):176-85. PubMed ID: 24891930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
    El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
    Scand J Gastroenterol; 2017; 52(6-7):691-697. PubMed ID: 28346031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome.
    El-Salhy M; Gundersen D; Hatlebakk JG; Hausken T
    Mol Med Rep; 2013 Apr; 7(4):1081-5. PubMed ID: 23417076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
    El-Salhy M; Lomholt-Beck B; Hausken T
    Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.